Literature DB >> 16225969

Induction of cytotoxic T-lymphocytes by electroporation-enhanced needle-free skin immunization.

Y L Zhao1, S N Murthy, M H Manjili, L J Guan, A Sen, S W Hui.   

Abstract

A needle-free method based on transcutaneous electroporation is described for delivering peptide vaccines. The K(b)-binding OVA-peptide SIINFEKL was used as an example to induce the peptide-specific cytotoxic T-lymphocytes (CTL) response in mice. A saturated anionic lipid was added during electroporation, and post-pulse electro-osmosis was applied to enhance the vaccine delivery. Electroporation was found to stimulate the exodus of Langerhans cells (LC) from the skin. The peptide transported into and through murine skin was measured using a Franz diffusion apparatus. Most peptide was retained in the skin rather than passing through the skin in the process. The peptide was delivered to the dorsal skin of mice by in vivo electroporation. An electroporation-transportable oligonucleotide with CpG motif was used as adjuvant. The efficacy of peptide delivery was comparable to that of intradermally injected with Freund's complete adjuvant (FCA). Peptide-specific CTL response to the vaccine delivered by needle-free electroporation/electro-osmosis was equivalent to that delivered by intradermal injection, as determined by production of the peptide-specific IFN-gamma in ELISPOT assay.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225969     DOI: 10.1016/j.vaccine.2005.09.035

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  18 in total

1.  Electroporation and transcutaneous sampling (ETS) of acyclovir.

Authors:  S Narasimha Murthy; Shuangqing Zhang
Journal:  J Dermatol Sci       Date:  2007-10-18       Impact factor: 4.563

Review 2.  Langerhans cells as targets for immunotherapy against skin cancer.

Authors:  Patrizia Stoitzner; Florian Sparber; Christoph H Tripp
Journal:  Immunol Cell Biol       Date:  2010-03-30       Impact factor: 5.126

Review 3.  Transdermal delivery of proteins.

Authors:  Haripriya Kalluri; Ajay K Banga
Journal:  AAPS PharmSciTech       Date:  2011-03-03       Impact factor: 3.246

4.  Dendritic cells recruitment in melanoma metastasis treated by electrochemotherapy.

Authors:  Gianni Gerlini; Serena Sestini; Paola Di Gennaro; Carmelo Urso; Nicola Pimpinelli; Lorenzo Borgognoni
Journal:  Clin Exp Metastasis       Date:  2012-06-27       Impact factor: 5.150

5.  Hollow copper sulfide nanoparticle-mediated transdermal drug delivery.

Authors:  Samy Ramadan; Liangran Guo; Yajuan Li; Bingfang Yan; Wei Lu
Journal:  Small       Date:  2012-07-25       Impact factor: 13.281

6.  Enhancement of protein vaccine potency by in vivo electroporation mediated intramuscular injection.

Authors:  Tae Heung Kang; Archana Monie; Lee S-F Wu; Xiaowu Pang; Chien-Fu Hung; T-C Wu
Journal:  Vaccine       Date:  2010-12-04       Impact factor: 3.641

7.  Enabling skin vaccination using new delivery technologies.

Authors:  Yeu-Chun Kim; Mark R Prausnitz
Journal:  Drug Deliv Transl Res       Date:  2011-02-01       Impact factor: 4.617

Review 8.  Transdermal drug delivery.

Authors:  Mark R Prausnitz; Robert Langer
Journal:  Nat Biotechnol       Date:  2008-11       Impact factor: 54.908

Review 9.  Transdermal drug delivery systems for fighting common viral infectious diseases.

Authors:  Fang-Ying Wang; Yunching Chen; Yi-You Huang; Chao-Min Cheng
Journal:  Drug Deliv Transl Res       Date:  2021-05-22       Impact factor: 4.617

Review 10.  Is There an Optimal Formulation and Delivery Strategy for Subunit Vaccines?

Authors:  Sharan Bobbala; Sarah Hook
Journal:  Pharm Res       Date:  2016-07-05       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.